Tru Niagen
Tru Niagen, a subsidiary of Chromadex, has specialized in an innovative variant of vitamin B3, called nicotinamide riboside. In 2004, Dr. discovered Charles Brenner, the Head of Scientific Advisory at Tru Niagen, the beneficial influence of nicotinamide riboside on the energy metabolism in our cells, which is an essential factor for healthy aging. With the patents of Dr. Brenner and ChromaDex's established technologies, Tru Niagen has exclusively licensed nicotinamide riboside and developed it under the Niagen® trademark.